PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,496,440 | +16.3% | 537,703 | +51.9% | 0.01% | +22.2% |
| Q2 2023 | $14,188,357 | +1656.6% | 354,099 | +1687.7% | 0.01% | +800.0% |
| Q1 2023 | $807,738 | +136.9% | 19,807 | +124.3% | 0.00% | – |
| Q4 2022 | $340,923 | -27.5% | 8,831 | +0.0% | 0.00% | – |
| Q3 2022 | $470,000 | -8.6% | 8,830 | +0.2% | 0.00% | – |
| Q2 2022 | $514,000 | -23.7% | 8,814 | -0.1% | 0.00% | – |
| Q1 2022 | $674,000 | -71.8% | 8,823 | -77.8% | 0.00% | -100.0% |
| Q4 2021 | $2,386,000 | -31.2% | 39,665 | -36.0% | 0.00% | -50.0% |
| Q3 2021 | $3,469,000 | -21.0% | 61,943 | -14.4% | 0.00% | 0.0% |
| Q2 2021 | $4,389,000 | -19.0% | 72,334 | -6.4% | 0.00% | 0.0% |
| Q1 2021 | $5,419,000 | -55.7% | 77,315 | -51.4% | 0.00% | -98.0% |
| Q4 2015 | $12,229,000 | +122.8% | 159,210 | +19.3% | 0.10% | +104.2% |
| Q3 2015 | $5,488,000 | -27.8% | 133,502 | +24.2% | 0.05% | -20.0% |
| Q2 2015 | $7,604,000 | -12.6% | 107,512 | +9.8% | 0.06% | -10.4% |
| Q1 2015 | $8,696,000 | +49.8% | 97,900 | +49.5% | 0.07% | +59.5% |
| Q4 2014 | $5,805,000 | +11.1% | 65,470 | +21.5% | 0.04% | -14.3% |
| Q3 2014 | $5,223,000 | – | 53,892 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |